Hyperrab 300 unit/ML vialml
Ended Awarded
- Contract number
- SPE2DB25FAXL9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,465
Award facts
- Contract value 100% obligated
- $3,465.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,465.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML Vial, a rabies immunoglobulin product used for post-exposure prophylaxis. The award was issued on May 27, 2025, with an ultimate completion date of June 17, 2025, and represents a non-competitive, non-set-aside procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables supply of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contracting presence as a critical vendor for military and veteran healthcare systems. The company's extensive portfolio with DLA encompasses a broad range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic areas. This specific HYPERRAB delivery order exemplifies AmerisourceBergen's role in providing specialized medical commodities to support Defense Health Agency and related government healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FAXL9?
SPE2DB25FAXL9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 27, 2025.
How much is contract SPE2DB25FAXL9 worth?
The government has obligated $3,465 on SPE2DB25FAXL9.
Is contract SPE2DB25FAXL9 an order under another contract?
Yes. SPE2DB25FAXL9 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAXL9 competed?
The extent of competition for SPE2DB25FAXL9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award